SCHEDULE: Darwin Global Discloses 7.8% Stake in Insmed

Darwin Global Management and Dr. Abhishek Trehan have reported a 7.8% beneficial ownership stake in Insmed Incorporated.

Summary

• Darwin Global Management, Ltd., Dr. Abhishek Trehan, and Darwin Global Master Fund, Ltd. filed a Schedule 13G indicating a collective beneficial ownership of 16,805,184 shares of Insmed Inc. common stock.
• This holding represents 7.8% of the company's total outstanding common stock, based on 215,852,149 shares outstanding as of March 6, 2026.
• The reporting persons maintain shared voting and dispositive power over the shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure reflecting existing institutional positioning rather than a change in company fundamentals.

Positives

• Institutional investment firm demonstrates significant long-term confidence by maintaining a substantial 7.8% equity position in the company.

Negatives

• None identified; this is a standard regulatory disclosure of beneficial ownership.

Risks

• Market volatility affecting the value of the investment.
• Potential for future divestment by the reporting persons which could impact share price liquidity.

Future Outlook

The filing states that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors exceeding the 5% ownership threshold, signaling stable institutional interest in the biotech sector.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors holding significant minority stakes in publicly traded companies.

Stakeholder Impact

• Shareholders may view the continued 7.8% stake as a sign of institutional stability.

Next Steps

• Continued monitoring of future 13G or 13D filings by the reporting persons for changes in position.

Key Dates

Keywords

Insmed, INSM, Schedule 13G, Beneficial Ownership, Darwin Global Management, Institutional Investor